Related references
Note: Only part of the references are listed.Absence of Severe Complications From SARS-CoV-2 Infection in Children With Rheumatic Diseases Treated With Biologic Drugs
Giovanni Filocamo et al.
JOURNAL OF RHEUMATOLOGY (2021)
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
Alexandre Sepriano et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Sara Monti et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Health Status of Patients Who Underwent Liver Transplantation During the Coronavirus Outbreak at a Large Center in Milan, Italy
Maria Francesca Donato et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
Lorenzo D'Antiga
LIVER TRANSPLANTATION (2020)
Covid-19 and Kidney Transplantation
Enver Akalin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York
Rebecca Haberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
Amr H. Sawalha et al.
CLINICAL IMMUNOLOGY (2020)
Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases
Jose L. Pablos et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
Marina Pollan et al.
LANCET (2020)
CHARACTERISTICS OF THE PATIENTS WITH POLYARTERITIS NODOSA IN JAPAN
M. Kawazoe et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
ASSESSMENT OF ADHERENCE TO TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
E. Egorova et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence
Beth Russell et al.
ECANCERMEDICALSCIENCE (2020)
Serious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-TNF or rituximab: data from the Spanish registry BIOBADASER 2.0
Tatiana Cobo-Ibanez et al.
RHEUMATOLOGY INTERNATIONAL (2014)
Rituximab-Induced T Cell Depletion in Patients With Rheumatoid Arthritis Association With Clinical Response
J. Melet et al.
ARTHRITIS AND RHEUMATISM (2013)
The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment
Joachim Listing et al.
RHEUMATOLOGY (2013)
Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis
Jarrod Franklin et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand - An open-label trial
PP Sfikakis et al.
ARTHRITIS AND RHEUMATISM (2005)
Share Paper
